Stocktoria
Core Laboratories Inc. /DE/ CLB
Core Laboratories Inc. /DE/ statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($9.06); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
P / E vs its own history
Core Laboratories Inc. /DE/ trades at about 19.8× earnings — below its 10-year norm (10-year range 20.5×–63.5×, median 31×).
Shaded band = 10-year range (20.5×–63.5×); dot = today's 19.8×.
Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 10.7% | 11.2% | 10.7% | 8.5% | 9.6% |
| Net margin | 5.6% | 6.0% | 7.2% | 4.0% | 4.2% |
| FCF margin | 4.9% | 8.5% | 2.8% | 3.0% | 4.9% |
| Return on assets | 5.1% | 5.4% | 6.3% | 3.4% | 3.4% |
| Return on equity | 10.9% | 12.4% | 16.3% | 10.6% | 12.3% |
| Debt / equity | 0.42× | 0.51× | 0.74× | 0.95× | — |
| Current ratio | 2.02 | 2.16 | 2.53 | 2.05 | — |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.